Investor Starboard Unhappy With Bristol-Myers' Deal to Buy Celgene

Activist investor Starboard is unhappy with Bristol-Myers’ deal to buy Celgene. The drugmaker’s fifth-largest shareholder, Dodge & Cox, is also unhappy with the deal.

from WSJ.com: US Business https://ift.tt/2T8o8Ea
via IFTTT